Introduction: The morbidity and mortality in late preterm neonates is higher than term neonates. The main reason is the relative physical and neurologic immaturity, though there is no significant difference in the weight or the size of the two groups. Objective: The study was conducted to compare the early neonatal morbidity and mortality (within first 7 days of life) in late preterm infants (34–36 6/7 weeks) with those in term neonates (37–41 6/7 weeks). Materials and Methods: This was a prospective study conducted from 01 January 2015 to 30 June 2015 in the department of Neonatology at a tertiary hospital. Results: Total 100 neonates were included in the study; fifty neonates in each group. Late preterm infants had significantly higher morbidity due to any cause, e.g. respiratory morbidity (p<0.05), jaundice (p<0.05), hypoglycemia (p<0.05), sepsis (p<0.05) and perinatal asphyxia (p<0.05). Early neonatal mortality in late preterm neonates was significantly higher than term neonates (p<0.05). Conclusion: Late preterm neonates are at high risk for morbidity and mortality as compared to term neonates. Journal of Armed Forces Medical College Bangladesh Vol.12(1) 2016: 44-47
Background: Birth defects usually present at birth and may cause morbidity and mortality in the newborn. These defects may involve any organ system of the body. Gradually the incidence is rising due to various etiologies. The objective of the study was to find out the frequency, types and etiology of birth defects. Materials & Methods: This cross-sectional study was done in a tertiary care hospital in Bangladesh. In this study, 100 neonates with birth defects were enrolled, thoroughly examined, investigated and evaluated. Then collected data were analyzed. Results: The frequency of birth defects in this study was 1.54%. The most frequent birth defect was club foot deformity i.e. 11% and the most frequently involved organ system was cardiovascular system i.e. 28%. Among the birth defects 78% were major and only 22% were minor. Among those children with birth defect mortality was 17%; 41% were referred to advanced center and 42% were improved and discharged. In some of the cases with birth defect chromosomal anomaly, congenital infection (TORCH), maternal diabetes was found as causing factor. Conclusion: The frequency of birth defects was found 1.54% and most of the birth defects were major defect. Club foot deformity was found as the most common birth defect. Bangladesh J Child Health 2020; VOL 44 (1) :8-12
Introduction: Neonatal sepsis remains an important cause of morbidity and mortality and often requires prompt empiric treatment. However, only a minority of babies who receive antibiotics for suspected sepsis have an infection. Antimicrobial exposure in infancy has important short-term and long-term consequences. There is no consensus regarding empirical antimicrobial regimens. Objective: To compare efficacy and benefits of short course (5 days) over the standard course (7 days) antibiotic treatment for neonatal sepsis. Materials and Methods: The study was a randomized controlled trial done in the neonatal ward in a tertiary level hospital comprising total 100 term neonates equally divided in to two groups by randomization where Group-I (5 days antibiotic therapy) was compared against Group-II (7 days antibiotic therapy) in clinical recovery, hospital stay, morbidity such as seizure, developmental delay etc and mortality. Results: The study results showed that both the Group-I and Group-II were comparable in baseline clinical data and predisposing factors; however, there was no significant difference between the two groups in clinical features e.g. hypotonia (24% vs 26%, p>0.05), poor primitive reflexes (46% vs 52%, p>0.05), temperature instability (34% vs 28%, p>0.05), feeding intolerance (16% vs 14%, p>0.05), apnea / respiratory distress (28% vs 34%, p>0.05) and in clinical outcome e.g. hospital stay (5.24±0.78 vs 7.86±0.42, p>0.05), recovery (86% vs 90%, p>0.05), death (14% vs 10%, p>0.05), seizure disorder (8% vs 6%, p>0.05) and developmental delay (6% vs 4%, p>0.05). Conclusion: This study showed that there was no significant difference between the study groups in clinical outcome, however, short course antibiotic (5 days) is equally effective but economically more beneficial to standard course antibiotic (7 days) therapy for neonatal sepsis. Journal of Armed Forces Medical College Bangladesh Vol.13(1) 2017: 124-127
Background: Seizures are common following perinatal asphyxia and may exacerbate secondary neuronal injury. Barbiturate therapy has been used for infants with perinatal asphyxia in order to prevent seizures. However, barbiturate therapy may adversely affect neurodevelopment leading to concern regarding its aggressive use in neonates. The objective of the study was to determine the effect of administering prophylactic barbiturate therapy on seizure control and mortality in term neonates following perinatal asphyxia.Methodology: This was a randomized controlled trial (RCT) of prophylactic phenobarbitone therapy in term asphyxiated neonates without clinical evidence of seizures when compared to controls conducted in the neonatal ward of Sher-e-Bangla Medical College Barisal from 1st January 2016 to 30th June 2016.Results: Among the 100 neonates equally divided into two groups, there was no significant difference found in clinical outcome e.g. seizures (8% vs. 12%, p > 0.05), neurological abnormality at discharge (10% vs. 14%, p >0.05), mortality (12% vs. 14%, p >0.05) and major neurological disability (14% vs. 18%, p >0.05).Conclusion: In this study, prophylactic phenobarbitone therapy did not significantly prevent seizures in asphyxiated neonates.Bangladesh J Child Health 2017; VOL 41 (3) :165-169
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.